Antibody-Drug Conjugates in Gynecologic Oncology: Advances, Challenges, and Future Directions.
The article is a narrative review of antibody–drug conjugates (ADCs) in gynecologic malignancies. It explains ADC str...
Ex vivo drug sensitivity testing predicts treatment outcomes in advanced ovarian cancer.
- Post category:Gynecologic Cancer
- Reading time:2 mins read
This study describes DRUGSENS, an ex vivo functional drug testing platform designed to guide personalized therapy in adv...
Development and validation of an artificial intelligence-based model for diagnosing benign, borderline, and malignant adnexal masses.
- Post category:Gynecologic Cancer
- Reading time:2 mins read
This study reports development and validation of an artificial intelligence model, Clinical-Ovarian Multi-Task Attention...
Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18-gene panel.
- Post category:Gynecologic Cancer
- Reading time:1 min read
This study prospectively evaluated a tumor-first multigene next-generation sequencing (NGS) approach in epithelial ovari...